Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Longevity Health Holdings, Inc.CTCX · Entity 8659 | Director | October 11, 2024 | November 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Longevity Health Holdings, Inc.
Report date October 11, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2034-10-11 | Direct | 76,878 |
Reported balance
After 2024-10-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-10-11 · Grant · Acquired 76,878 · Balance 76,878 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.88 · Expires 2033-10-09 | Direct | 76,878 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 76,878 F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy Carmell Insiders LLC | 7,598 |
Reported balance
Holding disclosure · report date 2024-10-11 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,598 F2: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date.
F2: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 11, 2024 Filed Nov 8, 2024 17:00 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | GrantStock Option (right to buy) · Derivative | 76,878 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0000950170-24-124219 · ownership.xml · derivative · entry 2 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,878 Underlying: Common Stock · 76,878 shares Expires 2034-10-11 F1 · derivative.exercise_date: Stock options vest as follows: 25% on the one-year anniversary of grant date, with the remaining 75% in 36 equal monthly installments thereafter, subject to continued service through each vesting date. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 1,009 | $0.51 | $514.59 |
DisclosureSEC source: 0000950170-24-105170 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 7,598 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 30, 2024 Filed Sep 4, 2024 16:34 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 87 | $0.57 | $49.59 |
DisclosureSEC source: 0000950170-24-103448 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 6,589 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 522 | $0.56 | $292.32 |
DisclosureSEC source: 0000950170-24-102372 · ownership.xml · nonDerivative · entry 2 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 6,502 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 16:30 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 599 | $0.56 | $335.44 |
DisclosureSEC source: 0000950170-24-102372 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,980 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (19.1%), Scott Frisch (15.3%), Kathryn Gregory (26.4%), Gilles Spenlehauer (15.3%), and Patrick Sturgeon (23.9%). The total amount invested in the LLC by these members was $130,750 as of the date of his filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 591 | $3.94 | $2,325.64 |
DisclosureSEC source: 0000950170-23-071167 · ownership.xml · nonDerivative · entry 2 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 5,381 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.93 to $3.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 17:13 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 313 | $3.61 | $1,130.52 |
DisclosureSEC source: 0000950170-23-071167 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 4,790 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.40 to $3.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 13, 2023 Filed Dec 13, 2023 21:37 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 869 | $5.57 | $4,841.46 |
DisclosureSEC source: 0000950170-23-070167 · ownership.xml · nonDerivative · entry 3 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 4,477 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.47 to $3.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 21:37 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 869 | $3.50 | $3,042.89 |
DisclosureSEC source: 0000950170-23-070167 · ownership.xml · nonDerivative · entry 2 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 3,608 F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 11, 2023 Filed Dec 13, 2023 21:37 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 870 | $3.53 | $3,068.58 |
DisclosureSEC source: 0000950170-23-070167 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 2,739 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.52 to $3.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 21:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 36 | $3.15 | $113.40 |
DisclosureSEC source: 0000950170-23-069156 · ownership.xml · nonDerivative · entry 5 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,869 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 07, 2023 Filed Dec 8, 2023 21:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 199 | $3.07 | $610.09 |
DisclosureSEC source: 0000950170-23-069156 · ownership.xml · nonDerivative · entry 4 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,833 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $3.01 to $3.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 487 | $3.03 | $1,477.02 |
DisclosureSEC source: 0000950170-23-069156 · ownership.xml · nonDerivative · entry 3 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,634 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $2.99 to $3.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 05, 2023 Filed Dec 8, 2023 21:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 277 | $3.10 | $860.03 |
DisclosureSEC source: 0000950170-23-069156 · ownership.xml · nonDerivative · entry 2 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 1,147 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
| December 04, 2023 Filed Dec 8, 2023 21:12 UTC | Longevity Health Holdings, Inc. CTCX · Entity 8659 | PurchaseCommon Stock | 870 | $3.00 | $2,608.61 |
DisclosureSEC source: 0000950170-23-069156 · ownership.xml · nonDerivative · entry 1 Spenlehauer Gilles · CIK 0001997250 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Carmell Insiders LLC Disclosed balance after: 870 F1 · ownership.nature: The reported shares acquired and beneficially owned by the Reporting Person represent his/her interest in shares purchased by Carmell Insiders, LLC ("LLC"). The sole purpose of the LLC is to enable certain of the Issuer's Board of Directors to acquire shares of the Issuer's common stock in accordance with the Issuer's Insider Trading Policy (i.e., during periods of time when its members are not in possession of material nonpublic information). The five members of the LLC and their respective percentage interest in it are as follows: David Anderson (21.7%), Scott Frisch (17.4%), Kathryn Gregory (21.7%), Gilles Spenlehauer (17.4%), and Patrick Sturgeon (21.7%). The total amount invested in the LLC by these members was $115,000 as of the date of this filing. The LLC is managed by a non-member, and the members disclaim any voting or investment authority over the LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.